Review of Myopia Management and Plano Announce New Content Partnership
SINGAPORE, April 6, 2021 /PRNewswire/ -- Review of Myopia Management (RMM) is pleased to announce a new partnership with the Singapore-based Healthtech company, Plano Pte Ltd. Under their new agreement, RMM and Plano will produce new educational content designed specifically for eye care professionals worldwide. By joining forces, the companies hope to expand their current platforms and engage with the growing international myopia management community.
Jobson Optical Group launched RMM in March 2019 to create and share the most up-to-date information and educational tools for eye care providers (ECPs). Over the last two years, RMM has established itself as the first multi-platform digital asset dedicated entirely to myopia management.
Plano entered the eye care field in late 2017 with the primary goal of protecting consumers' eyes in the face of a growing digital landscape. The company recognized the ever-increasing number of myopia cases worldwide and the projections that those figures are expected to surge in the coming years. With the help of the Singapore Eye Research Institute, Singapore National Eye Centre, National Health Innovation Centre, and Enterprise Singapore, they worked to create an ecosystem that consists of: 1) educational content and community engagement to raise awareness on eye health and myopia in parents and children; 2) a science-based and innovative app, the planoApp, that empowers children to safely use digital smart devices while reducing their exposure to the risk factors for myopia, such as excessive digital screen time, lack of outdoor activity, and unsafe face-to-screen distance; 3) planoEyecheck, a smart online web platform to allow for efficient, convenient, cost-effective and targeted optometry bookings and; 4) predictive analytics and artificial intelligence to identify high-risk children in need of early intervention to reduce the progression of their myopia. The Plano ecosystem is now trusted by almost 500,000 parents from 10 different countries, including the U.S. and Australia.
"Review of Myopia Management and Plano are world leaders in addressing the global myopia crisis. This new content partnership will enhance our mission to educate and motivate ECPs to become proactive in aggressively managing childhood myopia," said Dwight Akerman, OD, MBA, chief medical editor of Review of Myopia Management.
The Founding Managing Director of Plano, Associate Professor Mo Dirani, added that "To solve the global issue of myopia, a coordinated and comprehensive approach is needed, where specifically tailored education and awareness models play a central role. For this reason, partnering with the team at Review of Myopia Management made complete sense."
Because of RMM and Plano's similar goals in spreading awareness of myopia and educating ECPs about the benefits of myopia management treatments, this partnership will produce even more resources that can be used in myopia management by eye care professionals worldwide.
About Review of Myopia Management
Review of Myopia Management (RMM) is a leading source for eyecare professionals of clinical, practice management, and research information on myopia management. Since its inception in March 2019, RMM's multi-channel format delivers content across all digital media. Utilizing the knowledge of world-renowned researchers and clinicians, Review of Myopia Management is curated to ensure eyecare professionals can proactively manage myopic children.
About Plano
Plano was developed with a clear purpose; to save sight and empower lives. With a culture of disruptive thinking grounded in real scientific research, Plano promotes the use of innovative technology to provide a solution to help mitigate the public health, societal and economic issues posed by excessive device usage. Plano's Founding Managing Director, Associate Professor Mohamed Dirani, has dedicated his life to the study and research of myopia and is an Adjunct Associate Professor at Duke-NUS Medical School and an Honorary Principal Investigator at the Singapore Eye Research Institute (SERI) and the Centre for Eye Research Australia (CERA). In July 2020, Plano announced its strategic alliance with global ophthalmic leader, Santen Pharmaceutical. And in November 2020, Plano emerged as the winner of Galen Growth's World's Most Innovative HealthTech Startup 2020 Award from a field of 64 global HealthTech Startups.
For more information, visit plano.co
SOURCE Plano Pte Ltd
Share this article